Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : XXX | Published on : September 2022

Oligonucleotide Synthesis Market Overview

The report is titled as ‘Oligonucleotide Synthesis Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Oligonucleotide Synthesis market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

Reports & Insights Overview

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Oligonucleotide Synthesis market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Oligonucleotide Synthesis Market Segmentation

The oligonucleotide synthesis market is segmented on the basis of products & services, type, technology, disease type, nucleic acid type, application, and region.

By Products & Services




DNA Oligos

RNA Oligos


Other Synthesized Oligos




Oligo Synthesis

25 nmol

50 nmol

200 nmol

1000 nmol

10,000 nmol



By Type

Antisense Oligonucleotide-based Therapies

RNAi Oligonucleotide-based Therapies

CpG Oligonucleotide-based Therapies

By Technology



By Disease Type

Neurological Disorders

Infectious Diseases

Other Diseases

By Nucleic Acid Type



By Application







Nucleic Acid Aptamers






Gene Synthesis



By End User


Academic Research Institutes

CROs and CMOs

Diagnostic Laboratories

Pharmaceutical & Biotechnology Companies


By Region

North America

Latin America


Asia Pacific

Middle East


Oligonucleotide Synthesis Market Key Players

Some of the key participating players in oligonucleotide synthesis market are:

General Electric Co.

TAG Copenhagen A/S

Quintara Biosciences

Eton Bioscience, Inc.

Kaneka Corporation (Eurogentec)

Bioneer Corporation

GenScript Biotech Corporation

Maravai Life Sciences

Merck KGaA

Danaher Corporation

Thermo Fisher Scientific, Inc.

LGC Biosearch Technologies

Agilent Technologies, Inc.

Biogen Inc.

Sarepta Therapeutics, Inc.

Integrated DNA Technologies, Inc.

Eurofins Scientific SE

Biolegio B.V.


TriLink BioTechnologies, LLC

PolyGen GmbH


Biolytic Lab Performance Inc.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product developments and launches

Global Healthcare Industry Outlook

Oligonucleotide Synthesis Adoption Rate, by End User

Top Companies Historical Growth Rate

Pricing Impact

Advantages of Oligonucleotide Synthesis

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.

To learn more about this report, request a free sample copy

Select License Type

Frequently Asked Questions

The oligonucleotide synthesis market is estimated to reach at a value of US$ *** Mn by the end of 2022 and expected to reach at a value of US$ *** Mn by 2030 with a significant CAGR of ***%.

The base year for the report is 2021 in oligonucleotide synthesis market.

The oligonucleotide synthesis market is segmented on the basis of products & services, type, technology, disease type, nucleic acid type, application, and region.

Some of the key participating players in oligonucleotide synthesis market are: General Electric Co., TAG Copenhagen A/S, Quintara Biosciences, Eton Bioscience, Inc., Kaneka Corporation (Eurogentec), Bioneer Corporation, GenScript Biotech Corporation, Maravai Life Sciences, Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Agilent Technologies, Inc., Biogen Inc., Sarepta Therapeutics, Inc., Integrated DNA Technologies, Inc., Eurofins Scientific SE, Biolegio B.V., IBA GmbH, TriLink BioTechnologies, LLC, PolyGen GmbH, BioAutomation, Biolytic Lab Performance Inc.

Brooklyn Award